OpenURL Connection Search

Select item for more details and to access through your institution.

Additional Burden Averted in the United States From Use of MF59-Adjuvanted Seasonal Influenza Vaccine Compared With Standard Seasonal Influenza Vaccine Among Adults ≥65 Years.
Published in:
Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad429
By:
- McGovern, Ian;
- Sardesai, Aditya;
- Taylor, Alexandra;
- Toro-Diaz, Hector;
- Haag, Mendel
Publication type:
Article
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes.
Published in:
Infectious Diseases & Therapy, 2024, v. 13, n. 10, p. 2135, doi. 10.1007/s40121-024-01037-7
By:
- Kieffer, Alexia;
- Beuvelet, Matthieu;
- Moncayo, Gerald;
- Chetty, Mersha;
- Sardesai, Aditya;
- Musci, Robert;
- Hudson, Richard
Publication type:
Article
Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain.
Published in:
BMC Infectious Diseases, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12879-024-09642-0
By:
- Gil-Prieto, Ruth;
- Pérez, Jaime Jesus;
- Drago, Georgina;
- Kieffer, Alexia;
- Roïz, Julie;
- Kazmierska, Paulina;
- Sardesai, Aditya;
- de Boisvilliers, Solène;
- López-Belmonte, Juan Luis;
- Beuvelet, Matthieu;
- Aldean, Javier Alvarez
Publication type:
Article
Predicting the Societal Value of Lecanemab in Early Alzheimer's Disease in Japan: A Patient-Level Simulation.
Published in:
Neurology & Therapy, 2023, v. 12, n. 4, p. 1133, doi. 10.1007/s40120-023-00492-7
By:
- Igarashi, Ataru;
- Azuma, Mie Kasai;
- Zhang, Quanwu;
- Ye, Weicheng;
- Sardesai, Aditya;
- Folse, Henri;
- Chavan, Ameya;
- Tomita, Kiyoyuki;
- Tahami Monfared, Amir Abbas
Publication type:
Article
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
Published in:
Neurology & Therapy, 2023, v. 12, n. 3, p. 863, doi. 10.1007/s40120-023-00473-w
By:
- Tahami Monfared, Amir Abbas;
- Ye, Weicheng;
- Sardesai, Aditya;
- Folse, Henri;
- Chavan, Ameya;
- Aruffo, Elena;
- Zhang, Quanwu
Publication type:
Article
Estimated Societal Value of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Published in:
Neurology & Therapy, 2023, v. 12, n. 3, p. 795, doi. 10.1007/s40120-023-00460-1
By:
- Tahami Monfared, Amir Abbas;
- Ye, Weicheng;
- Sardesai, Aditya;
- Folse, Henri;
- Chavan, Ameya;
- Kang, Kang;
- Zhang, Quanwu
Publication type:
Article
Response to Fullarton et al.
Published in:
Journal of Infectious Diseases, 2023, v. 227, n. 11, p. 1335, doi. 10.1093/infdis/jiac489
By:
- Kieffer, Alexia;
- Beuvelet, Matthieu;
- Sardesai, Aditya;
- Musci, Robert;
- Milev, Sandra;
- Lee, Jason K H
Publication type:
Article
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.
Published in:
2022
By:
- Kieffer, Alexia;
- Beuvelet, Matthieu;
- Sardesai, Aditya;
- Musci, Robert;
- Milev, Sandra;
- Roiz, Julie;
- Lee, Jason K H
Publication type:
journal article

Found: 8